Galanin: structural requirements for binding and signal transduction in RINm5F insulinoma cells.
Receptors for galanin, a neuropeptide inhibiting insulin release, have been described on RINm5F insulinoma cells. To characterize structural requirements for binding and biological activity of galanin, we studied binding and inhibition of hormone stimulated intracellular cAMP-production of N-terminal galanin fragments and -analogues in RINm5F cells. Half-maximal binding and potency were the same for all peptides used. Active peptides had the following rank of potency: galanin = galanin(1-22(23)Cys) greater than galanin(1-29(4)NLe) greater than galanin(1-18) greater than galanin(1-29(7)DAla) greater than galanin(1-29(2)DTrp4NLe7DAla) greater than galanin(1-29(2)DTrp). Galanin(3-29) was inactive. Therefore the first two amino acids of the galanin molecule with the indole side chain of the tryptophane residue in the right steric position are crucial for receptor binding.
Department of Medicine, University of Göttingen, F.R.G.
B
B
Gallwitz
W E
WE
Schmidt
R
R
Schwarzhoff
W
W
Creutzfeldt
D000818:Animals; D001667:Binding, Competitive; D002460:Cell Line; D000242:Cyclic AMP / Q000378:metabolism; D019004:Galanin; D007340:Insulinoma; D007700:Kinetics; D009479:Neuropeptides / Q000378:metabolism*; D010190:Pancreatic Neoplasms; D010455:Peptides / Q000378:metabolism*; D051381:Rats; D044088:Receptors, Galanin; D011964:Receptors, Gastrointestinal Hormone / Q000378:metabolism*; D015398:Signal Transduction; D013329:Structure-Activity Relationship
D009479:Neuropeptides; D010455:Peptides; D044088:Receptors, Galanin; D011964:Receptors, Gastrointestinal Hormone; D019004:Galanin; D000242:Cyclic AMP